Immune Pharmaceuticals Announces the launch of REMAIN (TM)...

2017-02-21T10:57:18-08:00

Ceplene Currently Approved in Europe and IsraelREMAIN(TM) to be a pivotal study for US approval NEW YORK, Feb. 17, 2017 /PRNewswire/ — Immune Pharmaceuticals Inc. (Nasdaq: IMNP), will announce on ...